Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/oracle-focuses-on-health-sciences-partner-enablement--growth--and-accreditation-49591-3/;msg90356) was not found.

Search medicine news 1 oracle focuses on health sciences partner enablement growth and accreditation 49591 3 ;msg90356 at Google

Search medicine news 1 oracle focuses on health sciences partner enablement growth and accreditation 49591 3 ;msg90356 at Yahoo

Search medicine news 1 oracle focuses on health sciences partner enablement growth and accreditation 49591 3 ;msg90356 at Msn

Google
 
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)UVALDE Dr. Daniel Leskovar, a Texas AgriLife Research plant physiologist at the Texas AgriLife Research and Extension Center in Uvalde, has been investigating ways to help vegetable plants make a les
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
Breaking Biology News(10 mins):Stem cells battle for space 2Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Lower income women report more insurance-based discrimination during pregnancy, delivery 2Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 1Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 2Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 3Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 4Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 5Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 6Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 7Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 1Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 2Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 3Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 4Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 5361 1Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 5361 2
(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Rabbit Anti-ISOCITRATE DEHYDROGENASE Polyclonal Antibody, Unconjugated from AbD Serotec
... two highly efficient methods of identifying recom...consuming plasmid preparation. By using the large-...s to transfer partial colonies of E. coli bacteria...solutions provided by the kits and immediately run...
Biology Products:
Finntip Filter Tips, 10ul
...e safety precautions must be taken to anticipate t...ioactive, highly toxic, or infectious sample mater...ng the contamination risk caused by foreign DNA (e...lter have an integrated filter made of pure hydrop...
Avant E-Z Rack Premium Low Binding Pipet Tips
RNase-free Tips, 1000 l size
Medicine Products:
(Date:12/4/2009)Researchers from the National Institute of Standards and Technology (NIST) and the Naval Research Laboratory have developed a new way to introduce magnetic impurities in a semiconductor crystal by pro
(Date:12/4/2009)CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmer
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/4/2009)NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chroni
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2
(Date:12/4/2009)WINSTON-SALEM, N.C., Dec. 4 A new, $2.8 million, four-year federal grant will support researchers at the University of Pittsburgh School of Medicine and their collaborators at Wake Forest University
(Date:12/4/2009)WASHINGTON, Dec. 4 A simple, inexpensive computer tool that measures volume changes in the size of suspicious nodules in the lungs picked up by a CT scanner can rule out non-cancerous ones with almos
(Date:12/4/2009)INDIANAPOLIS, Dec. 4 The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 1BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 2BIO key 28R 29 International to Exhibit at Oracle 28R 29 OpenWorld 10306 3Ford and Labor Leaders Join Forces with March of Dimes 59191 1Ford and Labor Leaders Join Forces with March of Dimes 59191 2OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 1OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 2OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst 26amp 3B Youngs Entrepreneur Of The Year 28R 29 in the Health Sciences Category 14403 3